Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2003
05/29/2003US20030099957 Detection of vascular system disorders; obtain nucleotide sequence sample, sequence, detect polymorphisms, evaluate for vascular system disorders
05/29/2003US20030099956 Ligation of nucleotide sequence in sample; obtain nucleotide sequence sample, incubate with primer, polymerase and nucleotide triphosphates, amplify sequences, digest, ligate and recover nucleotide sequence product
05/29/2003US20030099955 Detection of enzyme modulators; obtain three dimensional structure of enzyme, design modulator to bind active site, incubate with test modulator, monitor adjustment in enzyme activity
05/29/2003US20030099954 Adjusting preferential biopolymers; obtain biopolymer sample, insert into analytical apparatus, heat and adjust biopolymer
05/29/2003US20030099953 Method and kit for identification for nucleic acid modification enzymes and inhibitors thereof
05/29/2003US20030099952 Microarrays with visible pattern detection
05/29/2003US20030099951 Classification of nucleotide sequences; obtain nucleotide sequence, immerse in buffer, apply electric field, evaluate migatory behavior
05/29/2003US20030099950 Molecular detection systems utilizing reiterative oligonucleotide synthesis
05/29/2003US20030099949 Generation of solid support for use in the analysis of preferential particles; prepare slurry, deposit on substrate and microparticles, immobilze particles and form matrix, recover solid sopport
05/29/2003US20030099948 Renaturation, reassociation, association and hybridization of nucleic acid molecules
05/29/2003US20030099946 Detection of fungal pathogens using the polymerase chain reaction
05/29/2003US20030099945 Parallel selex
05/29/2003US20030099943 Detecting reduced activation of tumor necrosis factor receptors; obtain cell, extract nucleotide sequences, detect homozygosity at preferential gene position, presence of homozygosity indicates loss of sensitivity to modulators
05/29/2003US20030099941 Invasion assay
05/29/2003US20030099939 Nucleic acid ladders
05/29/2003US20030099937 Generation ,of preferential nucleotide sequences; generate solid support joined to oligonucleotide, incubate with nucleotide sequence reaction mixture, expose to polymerase , recover nucleotide sequences
05/29/2003US20030099936 Method of identifying inhibitors of EBNA-1
05/29/2003US20030099933 Monitoring toxicity of drug treatment in humans; obtain blood sample, determine mitochondrial concentration, compare to control, adjustment in concentration indicates drug toxicity
05/29/2003US20030099932 Expression vector for as gene transfer and diagnostic tool in genetic engineering
05/29/2003US20030099930 Generation of preferential microarrays; obtain dendrimeric polyamine, generate solid support, recover solid support
05/29/2003US20030099928 Method of isolating unculturable microorganisms
05/29/2003US20030099927 Arrays for bringing two or more reagents in contact with one or more biological targets and methods for making and using the arrays
05/29/2003US20030099926 Response element compositions and assays employing same
05/29/2003US20030099925 Solid support for use in detection and analysis of gene interation in eukaryotes
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/29/2003US20030099662 Proteins
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099658 For high speed detection, selection, isolation, and targeting; comprises beta-lactam antibiotics
05/29/2003US20030099628 Preventing proliferation of a tumor, using heparinase III; use sequencing heparin-like glycosaminoglycans (HLGAGs), removing active heparan sulfate from a solution, inhibition of angiogenesis
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099619 Method and composition for targeting an adenoviral vector
05/29/2003US20030099614 2-Methoxyestradiol-induced apoptosis in cancer cells
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/29/2003US20030099580 Universal microscope slide cassette
05/29/2003US20030098271 Comprises species-immobilizing filter within tubular housing; for polymerase chain reaction (PCR)
05/29/2003US20030098234 Biosensor
05/29/2003US20030097824 Specimen vial sealing apparatus and method
05/28/2003EP1315099A1 Microbe analyzing system and method, and database
05/28/2003EP1314983A1 Bioanalytical measuring method for catalases and peroxidases, their conjugates, substrates, activators and inhibitors
05/28/2003EP1314980A2 A system for cell-based screening
05/28/2003EP1314978A1 Biosensor
05/28/2003EP1314787A2 The Midkine gene is associated with cancer
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314781A1 Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same
05/28/2003EP1314431A2 Newcastle disease virus for therapeutic use
05/28/2003EP1314040A2 Use of grf1 protein for screening molecules
05/28/2003EP1314039A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
05/28/2003EP1313973A1 Reaction card and use of same
05/28/2003EP1313885A2 Methods of using agents that modulate bone formation and inhibit adipogenesis
05/28/2003EP1313884A2 Improvements in and relating to marking using dna
05/28/2003EP1313883A2 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313881A2 Capture moieties for nucleic acids and uses thereof
05/28/2003EP1313880A2 Methods for detecting target nucleic acids using coupled ligation and amplification
05/28/2003EP1313879A2 Methods for the survey and genetic analysis of populations
05/28/2003EP1313878A1 Detection of copy number changes in colon cancer
05/28/2003EP1313876A2 Process for detecting enzyme activity in an immunoassay
05/28/2003EP1313874A1 Pharmaceutical compositions comprising a modulator of adamts-1
05/28/2003EP1313871A1 NUCLEOTIDE SEQUENCES WHICH CODE FOR THE metY GENE
05/28/2003EP1313867A2 Stress-regulated genes of plants, transgenic plants containing same, and methods of use
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313844A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313839A1 Immune potentiating compositions
05/28/2003EP1313768A2 Antisense oligonucleotides against vr1
05/28/2003EP1313766A2 Coaster, a human coactivator of steroid receptors
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313756A1 Antibodies specific for methylated lysines in histones
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313543A1 Device and methods for subdividing and filtering gel material and extracting molecules therefrom
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1303751A4 Dyes and methods of detection of nucleic acid in immature red blood cells
05/28/2003EP1155140B1 Methods for making morpholino-nucleotides, and their use for analysing and marking nucleic acid sequences
05/28/2003EP1135500A4 Control of flowering
05/28/2003EP1127156A4 Regulation of nitric oxide synthase activity
05/28/2003EP1092045A4 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS
05/28/2003EP1086216B1 Pseudo-cyclic oligonucleobases
05/28/2003EP0973877B1 Improved support layer for enzyme electrode laminated membranes
05/28/2003EP0973868A4 Evaluation of changes in breast cells using nipple aspirate fluid
05/28/2003EP0972078A4 Iterative resequencing
05/28/2003EP0925369B1 Universal test systems and methods of use thereof for identifying multiple families of microorganisms
05/28/2003EP0870056B1 Method for identifying an unknown allele
05/28/2003EP0843739A4 Molecular combing of macromolecules through the action of a meniscus on hihgly specific surfaces
05/28/2003EP0750747B1 Identification of amino acids by mass spectrometry
05/28/2003EP0652291B1 Probe for diagnosing infectious disease
05/28/2003EP0651783B1 Alkaline phosphatase enzyme having improved specific activity for use in indicator reagents
05/28/2003CN1420986A Method for prediction of preeclampsia and other diseases
05/28/2003CN1420984A Simple method of biologically evaluating natural and artificial chemicals by using DNA injury index and apparatus therefor
05/28/2003CN1420936A Identification of cells for transplantation
05/28/2003CN1420931A Methods and microorganisms for production of panto-compounds
05/28/2003CN1420929A Non-endogenous, constitutively activated known G protein-coupled receptors
05/28/2003CN1420928A Method for synthesizing nucleic acid
05/28/2003CN1420927A Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
05/28/2003CN1420923A Infection of eukaryotic cells with viruses in vitro
05/28/2003CN1420182A Probe sequence and kit for real time fluorescence PCR detection of transgenic potato
05/28/2003CN1420181A Probe sequence and kit for real time fluorescence PCR detection of transgenic rapeseed